Genomic classifier performance in intermediate-risk prostate cancer: Results from NRG Oncology/RTOG 0126 randomized phase III trial.
暂无分享，去创建一个
H. Sandler | P. Tran | É. Vigneault | F. Feng | A. Berlin | D. Spratt | E. Davicioni | J. Efstathiou | J. Robertson | J. Michalski | M. Parliament | E. Gore | T. Karrison | L. Souhami | W. Hall | V. Liu | I. Dayes | R. Correa | D. Doncals | D. Thompson | J. Simko